“Bimekizumab Efficacy through One Year in Patients With Moderate to Severe Plaque Psoriasis in Subgroups Defined by Prior Biologic Treatment: Pooled Results from Four Phase 3 3b Trials ”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, p. s64, https://doi.org/10.25251/skin.6.supp.64.